Journal of Nanobiotechnology

OCT 21, 2026 · JOURNAL ARTICLE

Engineering the bandgap of TiO2 nanorods through copper doping: a dual-modal strategy for radiosensitization and cuproptosis activation

Journal of Nanobiotechnology

Although titanium dioxide (TiO 2 ) semiconductor nanomaterials have garnered considerable attention in radiotherapy research due to their photoelectric effect, the inefficient elec

OCT 15, 2026 · JOURNAL ARTICLE

Extracellular vesicle-derived circ6853 drives vascular remodeling and serves as a potential biomarker and therapeutic target for gastric cancer

Journal of Nanobiotechnology

Gastric cancer (GC), a leading global malignancy, urgently requires the discovery of novel diagnostic and therapeutic targets. The roles of extracellular vesicle (EV)- derived circ

OCT 13, 2026 · JOURNAL ARTICLE

Carrier-free supramolecular co-assembly enables oxygen-economizing photodynamic therapy via mitochondrial respiration suppression

Journal of Nanobiotechnology

Hypoxia within the tumor microenvironment severely compromises the therapeutic efficacy of photodynamic therapy (PDT) by limiting oxygen-dependent reactive oxygen species (ROS) gen

OCT 12, 2026 · JOURNAL ARTICLE

Multimodal folate receptor-targeted liposomes enable photo-chemo-antibiotic synergy for peritoneal cancer therapy

Journal of Nanobiotechnology

The complex and heterogeneous nature of cancer presents significant challenges to effective treatment. Because no single therapy can overcome this complex challenge, rational combi

OCT 11, 2026 · JOURNAL ARTICLE

Therapy-induced senescence in cancer: from detection to intervention

Journal of Nanobiotechnology

Therapy-induced senescence (TIS) has emerged as an important contributor to treatment resistance and poor prognosis in clinical cancer therapy. Senescence initially acts as a tumor

OCT 10, 2026 · JOURNAL ARTICLE

Epigenetic-metabolic regulation of macrophage pyroptosis by FTO-m6A-NLRP3 axis: insights from multi-omics analysis

Journal of Nanobiotechnology

Sepsis, a severe illness marked by immune dysregulation and widespread inflammation, involves macrophage pyroptosis as a key player. This study explores the impact of RNA N6-methyl

OCT 3, 2026 · JOURNAL ARTICLE

MMP-9–responsive stealth-to-activation liposomes enable tumor-selective PD-L1 degradation via dual-PEG shedding

Journal of Nanobiotechnology

Abstract PD-1/PD-L1 blockade benefits patients across > 20 cancer types, yet durable responses remain limited and antibody therapies only transiently engage the axis while causing

OCT 1, 2026 · JOURNAL ARTICLE

Nanodelivery of the NANOG-CD2 peptide impairs RAD51-mediated DNA repair and sensitizes cervical cancer cells to cisplatin

Journal of Nanobiotechnology

Acquired cisplatin resistance remains a major challenge in cancer therapy and is frequently associated with enhanced RAD51-mediated homologous recombination (HR) repair. Here, we i